Correlates of depression among HIV-positive women and men who inject drugs

Journal of Acquired Immune Deficiency Syndromes

Volumn 46, Issue SUPPL. 2, 2007, Pages

  Valverde, Eduardo E ^a,b   Purcell, David W ^b   Waldrop Valverde, Drenna ^a   Malow, Robert ^c   Knowlton, Amy R ^d   Gómez, Cynthia A ^e   Farrell, Nisha ^c   Latka, Mary H ^f  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NEW YORK ACADEMY OF MEDICINE   (United States)

Author keywords

Depression; Gender; HIV; Injection drug use

Indexed keywords

ADULT; ARTICLE; CORRELATION ANALYSIS; DEPRESSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MALE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SOCIAL SUPPORT;

ADOLESCENT; ADULT; DATA COLLECTION; DEPRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SELF DISCLOSURE; SEX FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 37349123876     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318157683b     Document Type: Article

References (35)

1. Weiser SD, Riley ED, Ragland K, et al. Brief report: factors associated with depression among homeless and marginally housed HIV-infected men in San Francisco. J Gen Intern Med. 2006;21:61-64.
2. Haug NA, Sorensen JL, Lollo ND, et al. Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial. AIDS Care. 2005;17:1022-1029.
3. Williams P, Narciso L, Browne G, et al. The prevalence, correlates, and costs of depression in people living with HIV/AIDS in Ontario: implications for service directions. AIDS Educ Prev. 2005;17:119-130.
4. Hinkin CH, Castellon SA, Atkinson JH, et al. Neuropsychiatric aspects of HIV infection among older adult. J Clin Epidemiol. 2001;54(Suppl 1):S44-S52.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
6. Satz P, Myers HF, Maj M, et al. Depression, substance use and sexual orientation as co-factors in HIV-1 infected men: cross-cultural comparisons. NIDA Res Monogr. 1997;172:130-155.
7. Ammassari A, Antinori A, Aloisi MS, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics. 2004;45:394-402.
8. Yun LW, Maravi M, Kobayashi JS, et al. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr. 2005;38:432-438.
9. Reynolds NR, Testa MA, Marc LG, et al. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study. AIDS Behav. 2004;8:141-150.
10. Weiser SD, Riley ED, Ragland K, et al. Brief report: factors associated with depression among homeless and marginally housed HIV-infected men in San Francisco. J Gen Intern Med. 2006;21:61-64.
11. Ironson G, O'Cleirigh C, Fletcher MA, et al. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med. 2005;67:1013-1021.
12. Cook JA, Grey D, Burke J, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health. 2004;94:1133-1140.
13. Cohen MH, French AL, Benning L, et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med. 2002;113:91-98.
14. Wisniewski AB, Apel S, Selnes OA, et al. Depressive symptoms, quality of life, and neuropsychological performance in HIV/AIDS: the impact of gender and injection drug use. J Neurovirol. 2005;11:138-143.
15. Moneyham L, Murdaugh C, Phillips K, et al. Patterns of risk of depressive symptoms among HIV-positive women in the southeastern United States. J Assoc Nurses AIDS Care. 2005;16:25-38.
16. Jia H, Uphold CR, Wu S, et al. Health-related quality of life among men with HIV infection: effects of social support, coping, and depression. AIDS Patient Care STDS. 2004;18:594-603.
17. Blaney NT, Fernandez MI, Ethier KA, et al. Perinatal Guidelines Evaluation Project Group. Psychosocial and behavioral correlates of depression among HIV-infected pregnant women. AIDS Patient Care STDS. 2004;18:405-415.
18. Centers for Disease Control and Prevention. Drug-associated HIV transmission continues in the United States. Available at: http://www.cdc. gov/hiv/resources/factsheets/idu.htm. Accessed February 22, 2007.
19. Mizuno Y, Purcell DW, Dawson-Rose C, et al. Correlates of depressive symptoms among HIV-positive injection drug users: the role of social support. AIDS Care. 2003;15:689-698.
20. Waldrop-Valverde D, Ownby RL, Kumar M. Influence of depression and HIV serostatus on the neuropsychological performance of injecting drug users. Psychiatry Clin Neurosci. 2005;59:372-378.
21. Knowlton AR, Latkin CA, Schroeder JR, et al. Longitudinal predictors of depressive symptoms among low income injection drug users. AIDS Care. 2001;13:549-559.
22. Himelhoch S, Medoff DR. Efficacy of antidepressant medication among HIV-positive individuals with depression: a systematic review and meta-analysis. AIDS Patient Care STDS. 2005;19:813-822.
23. Purcell DW, Metsch LR, Latka M, et al. Interventions for seropositive injectors - research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. J Acquir Immune Defic Syndr. 2004;37(Suppl 2):S110-S118.
24. Derogatis LR, Spencer PM. The Brief Symptom Inventory (BSI-18): Administration, Scoring, and Procedural Manual-1. Baltimore, MD: John Wiley; 2001.
25. Anastasi A. Psychological testing. 6th ed. New York: Macmillan Publishing Company; 1988.
26. Waldrop-Valverde D, Valverde E. Homelessness and psychological distress as contributors to antiretroviral non-adherence in HIV-positive injecting drug users. AIDS Patient Care STDS. 2005;19:326-334.
27. Mills TC, Paul J, Stall R, et al. Distress and depression in men who have sex with men: the Urban Men's Health Study. Am J Psychiatry. 2004;161:278-285.
28. Kalichman SC, Sikkema KJ, DiFonzo K, et al. Emotional adjustment in survivors of sexual assault living with HIV-AIDS. J Trauma Stress. 2002; 15:289-296.
29. Barrera MA. A method for assessing social support networks in community survey research. Connections. 1980;3:8-13.
30. Rogers ES, Chamberlin J, Ellison ML, et al. A consumer-constructed scale to measure empowerment among users of mental health services. Psychiatr Serv. 1997;48:1042-1047.
31. Porcerelli JH, Cogan R, West PP, et al. Violent victimization of women and men: physical and psychiatric symptoms. J Am Board Fam Pract. 2003;16:32-39.
32. George MJ. Riding the donkey backwards: men as the unacceptable victims of marital violence. The Journal of Men's Studies. 1994;3:137-159.
33. Lipsitz JD, Williams JB, Rabkin JG, et al. Psychopathology in male and female intravenous drug users with and without HIV infection. Am J Psychiatry. 1994;151:1662-1668.
34. Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs. 2006;66:769-789.
35. Myrick H, Cluver J, Swavely S, et al. Diagnosis and treatment of cooccurring affective disorders and substance use disorders. Psychiatr Clin North Am. 2004;27:649-59.